Drug details

Releuko (filgrastim-ayow injection)

type of Chemotherapy Modulating Agents

Releuko (filgrastim-ayow) is a leukocyte growth factor indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever; reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML); reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT); and reduce the incidence and duration of sequelae of severe neutropenia‚ (e.g., fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.

This drug may have the following side effects:
  • shortness of breath,
  • nausea,
  • sweating,
  • lightheadedness,
  • vomiting,
  • sore throat,
  • loss of appetite,
  • fever,
  • chills,
  • stomach pain,
  • pale skin,
  • tiredness,
  • hives, 
  • difficulty breathing, 
  • swelling of your face, lips, tongue, or throat, 
  • wheezing, 
  • easy bruising, 
  • back pain,
  • flu symptoms,
  • severe dizziness,
  • fast heart rate,
  • unusual tiredness, 
  • unusual weakness
  • cold hands and feet, 
  • blood in your urine, 
  • rapid breathing,
  • little or no urinating, 
  • mouth sores, and
  • pain while breathing, 
  • swelling or puffiness, 
  • felling full, 
  • swelling in your face or ankle, 
  • unusual bleeding (nosebleeds, bleeding gums), 
The following drugs are related to Releuko, either as a replacement or used together:
  • Alecensa (alectinib capsules)
  • Victrelis (boceprevir capsules)
  • Neupogen (filgrastim injection)
  • Zarxio (filgrastim-sndz injection)
  • Harvoni (ledipasvir and sofosbuvir tablets)
  • Incivek (telaprevir film-coated tablets)
  • Infergen (interferon alfacon-1)
  • Olysio (simeprevir hard gelatin capsules)
  • Technivie (ombitasvir, paritaprevir and ritonavir tablets)
  • Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets)
  • Rebetol (ribavirin)
  • Sovaldi (sofosbuvir tablets)
  • Yondelis (trabectedin for injection)